Expedited Development Enabled by RMAT and Breakthrough Therapy StatusClinical Trial Initiation in 2026, FDA Approval Target ...
A ground-breaking study by a team of scientists from Hyderabad-based Cellular and Molecular Biology (CCMB) has revealed that cells have a built-in ability to return from the brink of death and even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback